CA 125, CA 15.3, CA 27.29, CEA, β-hCG and α-fetoprotein levels in cyst fluid of breast macrocysts
Objective: To determine the tumoral markers CA 125, CA 15.3, CA 27.29, CEA, β-hCG and α-fetoprotein in serum and breast cystic fluid in women with fibrocystic breast disease. Methods: The study comprised 50 women diagnosed with fibrocystic breast disease but without breast macrocysts, and 60 women w...
Gespeichert in:
Veröffentlicht in: | International journal of gynecology and obstetrics 1995-02, Vol.48 (2), p.187-192 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Objective: To determine the tumoral markers CA 125, CA 15.3, CA 27.29, CEA, β-hCG and α-fetoprotein in serum and breast cystic fluid in women with fibrocystic breast disease.
Methods: The study comprised 50 women diagnosed with fibrocystic breast disease but without breast macrocysts, and 60 women with macrocysts.
Results: Significantly higher levels of CA 125, CA 27.29, β-hCG and CEA were observed in the cyst fluid than in the serum of the same patients. According to their
K
+
Na
+
quotient we found that when
K
+
Na
+
was 3, only CA 27.29 and β-hCG levels were significantly higher. Comparing cyst fluid marker levels with respect to the
K
+
Na
+
ratio, the only difference observed was in CA 125 which was significantly greater when
K
+
Na
+
was < 3. A negative correlation was found between CA 125 and the
K
+
Na
+
quotient.
Conclusion: These results suggest that CA 125 could be used as a marker to identify cyst type. |
---|---|
ISSN: | 0020-7292 1879-3479 |
DOI: | 10.1016/0020-7292(94)02279-8 |